Sosenko JM, Kato M, Soto R, Bild DE. A prospective study of sensory function in patients with type 2 diabetes. Diabet Med 1993; 10: 110-4.
[53] Young RJ, Macintyre CCA, Martyn CN, Prescott RJ, Ewing DJ, Smith AF, Viberti G, Clarke BF. Progression of subclinical polyneuropathy in young patients with type 1 (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications). Diabetologia 1986; 29: 156-61.
[54] Young RJ, Macintyre CCA, Ewing DJ, Prescott RJ. Prediction of neuropathy over 5 years in young insulin-dependent diabetic patients. Diabet Med 1988; 5: 7.
[55] Benbow SJ, Chan AW, Bowsher D, MacFarlane IA, Williams G. A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabet Med 1994; 11: 17-21.
[56] Ziegler D, Piolot R. Prevention of diabetic neuropathy by near-normoglycemia. A 12-year prospective study from the diagnosis of IDDM. Diabetes 1998; 47 (Suppl 1): A63.
[57] Macleod AF, Till S, Sönksen PHS. Discussion of the clinical trials of the aldose reductase inhibitor tolrestat. Int Proc J 1991; 4: 17-24.
[58] Negrin P, Zara G. Conduction studies as prognostic parameters in the natural history of diabetic neuropathy: a long-term follow-up of 114 patients. Electromyogr Clin Neurophysiol 1995; 35: 341-50.
[59] Watanabe K, Hagura R, Akanuma Y, Takasu T, Kajinuma H, Kuzuya N, Irie M. Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 1990; 10: 19-27.
[60] Longstreth GF. Diabetic thoracic polyradiculopathy: ten patients with abdominal pain. Am J Gastroenterol 1997; 92: 502-5.
[61] Neil HA, Thompson AV, John S, McCarthy ST, Mann JI. Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population. Diabet Med 1989; 6: 20-4.
[62] Maser RE, Pfeifer MA, Dorman JS, Kuller LH, Becker DJ, Orchard TJ. Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 1990; 150: 1218-22.
[63] O'Brien IAD, O'Hare JP, Lewin IG, Corrall RJM. The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled study based on heart rate variability. Q J Med 1986; 61: 957-67.
[64] Stephenson J, Fuller JH, and EURODIAB IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study, Diabetologia 1994; 37: 278-85.
[65] Tsutsu N, Nunoi K, Yokomizo Y, Kikuchi M, Fujishima M. Relationship between glycemic control and orthostatic hypotension in type 2 diabetes mellitus–a survey by the Fukuoka Diabetes Clinic Group. Diabetes Res Clin Pract 1990; 8: 115-23.
[66] Ziegler D, Dannehl K, Spüler M, Mühlen H, Gries FA. Prevalence of cardiovascular autonomic nerve dysfunction assessed by spectral analysis and standard tests of heart rate variation in newly diagnosed IDDM patients. Diabetes Care 1992; 15: 908-11.
[67] Lehtinen JM, Uusitupa M, Siitonen O, Pyörälä K. Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 1989; 38: 1307-13.
[68] Töyry JP, Niskanen LK, Mäntysaari MJ, Länsimies EA, Uusitupa MIJ. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM, Ten-year follow up from the diagnosis. Diabetes 1996; 45: 308-15.
[69] Töyry JP, Niskanen LK, Lansimies EA, Partanen KPL, Uusitupa MIJ. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1996; 27: 1316-8.
[70] Mustonen J, Uusitupa M, Mäntysaari M, Länsimies E, Pyörälä K, Laakso M. Changes in autonomic nervous function during the 4-year follow-up in middle-aged diabetic and nondiabetic subjects initially free of coronary heart disease. J Intern Med 1997; 241: 227-35.
[71] Quadri R, Ponzani P, Zanone M, Maule S, Grotta A La, Papotti G, Valentini M, Matteoda C, Chiandussi L, Fonzo D. Changes in autonomic nervous function over a 5-year period in non-insulin-dependent diabetic patients. Diabet Med 1993; 10: 916-9.
[72] Ziegler D, Mayer P, Mühlen H, Gries FA. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1991; 34: 822-9.
[73] Solders G, Thalme B, Aguirre-Aquino M, Brandt L, Berg U, Persson A. Nerve conduction and autonomic nerve function in diabetic children. Acta Paediatr 1997; 86: 361-6.
[74] Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ. Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. QJ Med 1990; 75: 635-46.
[75] Sundkvist G, Lilja B. Autonomic neuropathy in diabetes mellitus: a follow-up study. Diabetes Care 1985; 8: 129-33.
[76] Donaghue KC, Fung ATW, Fairchild JM, Howard NJ, Silink M. Prospective assessment of autonomic and peripheral nerve function in adolescents with diabetes. Diabet Med 1996; 13: 65-71.
[77] Levitt NS, Stansberry KB, Wynchank S, Vinik AI. The natural progression of autonomic neuropathy aund autonomic function tests in a cohort of people with IDDM. Diabetes Care 1996; 19: 751-4.
[78] Sundkvist G, Lilja B. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 1993; 16: 773-9.
[79] Ziegler D, Piolot R, Pour Mirza A, Karallus M, Feng B, Schommartz B, Schadewaldt P. 13C-octanoic acid breath test to assess diabetic gastroparesis: patterns of gastric emptying in newly diagnosed and long-term type 1 and type 2 diabetic patients. Clin Auton Res 1997; 7: 246.
[80] Enck P, Rathmann W, Spiekermann M, Czerner D, Tschöpe D, Ziegler D, Strohmeyer G, Cries FA. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol 1994; 32: 637-41.
[81] Schvarcz E, Palmer M, Ingberg CM, Aman J, Berne C. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med 1996; 13: 478-81.
[82] Ko GTC, Chan W-B, Chan JCN, Tsang LWW, Cockram CS. Gastrointestinal symptoms in Chinese patients with type 2 diabetes mellitus. Diabet Med 1999; 16: 670-4.
[83] Santis A De, Attili AF, Corradini SG, Scafato E, Cantagalli A, Luca C De, Pinto G, List D, Capocaccia L. Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology 1997; 25: 787-90.
[84] Shaw JE, Parker R, Hollis S, Gokal R, Boulton AJM. Gustatory sweating in diabetes mellitus. Diabet Med 1996; 13: 1033-7.
[85] NIH consensus development panel on impotence. Impotence. JAMA 1993; 270: 83-90.
[86] Wagner G, Saenz de Tejada I. Update on male erectile dysfunction. BMJ 1998; 316: 678-82.
[87] Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male ageing study. J Urol 1994; 151: 54-61.
[88] Fedele D, Coscelli C, Santeusanio F, Bortolotti A, Chatenoud L, Colli E, Landoni M, Parazzini F. Erectile dysfunction in diabetic subjects in Italy. Diabetes Care 1998; 21: 1973-7.
[89] Kolodny RC, Kahn CB, Goldstein HH, Barnett DM. Sexual dysfunction in diabetic men. Diabetes 1974; 23: 306-9.
[90] Klein R, Klein PEK. Lee KE, Moss SE, Cruickshanks KJ. Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 1996; 19: 135-41.
[91] McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia 1980; 18: 279-83.
[92]
